Ontrak (Ontrak) Risk Assessment

View and export this data going back to 2002. Start your Free Trial

What is Ontrak Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Ontrak is: High Risk: High uncertainty.

Competitive Comparison of Ontrak's Risk Assessment

For the Health Information Services subindustry, Ontrak's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ontrak's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ontrak's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Ontrak's Risk Assessment falls into.

Ontrak (NAS:OTRK) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Ontrak Risk Assessment Related Terms

Thank you for viewing the detailed overview of Ontrak's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Ontrak (Ontrak) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ontrak Inc (NAS:OTRK) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

OTRKP.PFD:USA HY10:Germany HY10:Germany

Address

2200 Paseo Verde Parkway, Suite 280, Henderson, NV, USA, 89052

Website

https://www.ontrakhealth.com

Ontrak Inc is an AI and telehealth-enabled, virtualized outpatient healthcare treatment company. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. The company's technology-enabled platform provides claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of our personalized treatment program.

Executives

Judith Feld	officer: Chief Medical Officer	2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
James M. Messina	director	2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
Arik Hill	officer: Chief Information Officer	2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Robert Accordino	officer: Chief Medical Officer	2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Mary Louise Osborne	officer: Chief Customer Officer	2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
James J Park	officer: Chief Accounting Officer	2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Jonathan E. Mayhew	officer: Chief Executive Officer	ONE CVS DRIVE, WOONSOCKET RI 02895
Terren S Peizer	director, 10 percent owner, officer: CEO	11111 SANTA MONICABLVD STE.500, LOS ANGELES CA 90025
Robert I Newton	officer: General Counsel and Secretary	1940 E. MARIPOSA AVE, ATTN: BRANDON LAVERNE, EL SEGUNDO CA 90245
Katherine B Quinn	director	US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402
Robert Rebak	director	2120 COLORADO BLVD., SUITE 230, SANTA MONICA CA 90404
Curtis Medeiros	officer: Chief Operating Officer	2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Brandon H Laverne	officer: Chief Financial Officer	1940 E. MARIPOSA AVE., ATTN: BRANDON LAVERNE, EL SEGUNDO CA 90245
David E Smith	10 percent owner	888 LINDA FLORA DRIVE, LOS ANGELES CA 90049
Gustavo A Giraldo	director	2120 COLORADO AVENUE, SUITE 230, SANTA MONICA CA 90404